Combination of Irinotecan and Temozolomide in Children With Brain Tumors.
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
This study will assess the rate of objective confirmed tumor response of irinotecan in
combination with temozolomide in children with recurrent or refractory medulloblastoma and in
children with newly diagnosed high-grade glioma.